Articles

LogicBio Articles

October 5, 2020BioSpaceNews

LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of g... See more »
October 1, 2020BioSpaceNews

LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock

LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBio), a company dedicated to extending the reach of g... See more »
September 26, 2020Markets InsiderNews

LogicBio Therapeutics to Present at the 4th Annual Chardan Virtual Genetic Medicines Conference October 5, 2020 | Markets Insider

LEXINGTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a gen... See more »
August 13, 2020Zolmax NewsNews

Q3 2020 EPS Estimates for LogicBio Therapeutics Inc Lifted by Analyst (NASDAQ:LOGC)

LogicBio Therapeutics Inc (NASDAQ:LOGC) - Investment analysts at William Blair boosted their Q3 2020 ... See more »
August 10, 2020NewsOkNews

2Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ LogicBio Therapeutics Inc.Read more on NewsOK.com... See more »
June 5, 2020BioSpaceNews

LogicBio Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders - June 05, 2020

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably trea... See more »
May 28, 2020centralchartsPress Release

LogicBio Therapeutics to Present at the Jefferies Virtual Healthcare Conference

LEXINGTON, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »
May 11, 2020GlobeNewswirePress Release

LogicBio Reports First Quarter 2020 Financial Results and Provides Business Updates

LEXINGTON, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »
April 29, 2020NewsFilePress Release

The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against LogicBio Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - April 29, 2020) - The Schall Law Firm, a national sharehol... See more »
April 15, 2020GlobalNewswirePress Release

ROSEN, A RANKED AND LEADING FIRM, Reminds LogicBio Therapeutics, Inc. Investors of the Important May 18th Deadline in Securities Class Action - LOGC

NEW YORK, April 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, remin... See more »
April 12, 2020centralchartsPress Release

ROSEN, A TOP LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors With Large Losses of the May 18th Deadline in Class Action Seeking Recovery of Investor Losses - LOGC

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio T... See more »
February 10, 2020centralchartsPress Release

LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic Acidemia

CAMBRIDGE, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a geno... See more »
August 13, 2019GlobeNewswirePress Release

LogicBio Reports Second Quarter 2019 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicB... See more »
July 16, 2019GlobeNewswirePress Release

LogicBio Therapeutics Receives Rare Pediatric Disease Designation for LB-001 for the Treatment of Methylmalonic Acidemia

CAMBRIDGE, Mass., July 16, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a geno... See more »
May 14, 2019GlobeNewswirePress Release

LogicBio Reports First Quarter 2019 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (LogicBi... See more »
April 1, 2019GlobeNewswirePress Release

LogicBio Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates

CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC) (Logic... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...